Cargando…
Genome Surgery and Gene Therapy in Retinal Disorders
The emergence of genome surgery techniques like the clustered regularly interspaced short palindromic repeats (CRISPR) editing technology has given researchers a powerful tool for precisely introducing targeted changes within the genome. New modifications to the CRISPR-Cas system have been made sinc...
Autores principales: | Chan, Lawrence, Mahajan, Vinit B., Tsang, Stephen H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
YJBM
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733860/ https://www.ncbi.nlm.nih.gov/pubmed/29259518 |
Ejemplares similares
-
Translation of CRISPR Genome Surgery to the Bedside for Retinal Diseases
por: Xu, Christine L., et al.
Publicado: (2018) -
CRISPR-Cas Genome Surgery in Ophthalmology
por: DiCarlo, James E., et al.
Publicado: (2017) -
Correction of Monogenic and Common Retinal Disorders with Gene Therapy
por: Sengillo, Jesse D., et al.
Publicado: (2017) -
Retinal Manifestations of Mitochondrial Oxidative Phosphorylation Disorders
por: Oh, Jin Kyun, et al.
Publicado: (2020) -
Stem Cell Therapies in Retinal Disorders
por: Garg, Aakriti, et al.
Publicado: (2017)